Wave Total Revenue vs Cost Of Revenue Analysis
WVE Stock | USD 5.85 0.06 1.04% |
Wave Life financial indicator trend analysis is more than just analyzing Wave Life Sciences current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Wave Life Sciences is a good investment. Please check the relationship between Wave Life Total Revenue and its Cost Of Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Total Revenue vs Cost Of Revenue
Total Revenue vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Wave Life Sciences Total Revenue account and Cost Of Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Wave Life's Total Revenue and Cost Of Revenue is -0.02. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Wave Life Sciences, assuming nothing else is changed. The correlation between historical values of Wave Life's Total Revenue and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Wave Life Sciences are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Total Revenue i.e., Wave Life's Total Revenue and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | -0.02 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Total Revenue
Total revenue comprises all receipts Wave Life Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Cost Of Revenue
Cost of Revenue is found on Wave Life Sciences income statement and represents the costs associated with goods and services Wave Life provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Wave Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Wave Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. As of May 9, 2024, Selling General Administrative is expected to decline to about 33.7 M. The current year's Tax Provision is expected to grow to about (643.1 K)
Wave Life fundamental ratios Correlations
Click cells to compare fundamentals
Wave Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Wave Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 284.3M | 279.2M | 207.0M | 146.4M | 274.9M | 200.5M | |
Short Long Term Debt Total | 32.5M | 29.3M | 29.9M | 37.6M | 32.1M | 20.4M | |
Other Current Liab | 16.2M | 12.0M | 14.9M | 17.6M | 16.8M | 10.6M | |
Total Current Liabilities | 118.2M | 121.0M | 64.2M | 71.5M | 186.4M | 195.8M | |
Total Stockholder Equity | 63.7M | 82.8M | 32.5M | (45.1M) | 47.5M | 49.3M | |
Other Liab | 65.2M | 42.0M | 77.5M | 80.0M | 92.0M | 96.6M | |
Property Plant And Equipment Net | 54.5M | 45.4M | 40.6M | 44.1M | 35.7M | 30.2M | |
Current Deferred Revenue | 89.7M | 91.6M | 37.1M | 31.6M | 150.1M | 157.6M | |
Net Debt | (114.6M) | (155.2M) | (120.6M) | (50.9M) | (168.2M) | (176.6M) | |
Retained Earnings | (533.4M) | (683.3M) | (805.5M) | (967.3M) | (1.0B) | (973.6M) | |
Accounts Payable | 9.1M | 13.8M | 7.3M | 16.9M | 12.8M | 8.9M | |
Cash | 147.2M | 184.5M | 150.6M | 88.5M | 200.4M | 140.1M | |
Non Current Assets Total | 98.8M | 49.2M | 44.4M | 47.8M | 39.6M | 42.5M | |
Other Assets | 44.3M | 3.8M | 3.8M | 3.7M | 4.3M | 4.1M | |
Cash And Short Term Investments | 147.2M | 184.5M | 150.6M | 88.5M | 200.4M | 140.1M | |
Net Receivables | 10M | 20M | 30M | 0.0 | 21.1M | 22.1M | |
Common Stock Total Equity | 539.5M | 694.1M | 749.9M | 802.8M | 923.3M | 969.4M | |
Common Stock Shares Outstanding | 33.9M | 39.2M | 51.8M | 78.9M | 106.1M | 111.4M | |
Liabilities And Stockholders Equity | 284.3M | 279.2M | 207.0M | 146.4M | 274.9M | 200.5M | |
Non Current Liabilities Total | 102.4M | 75.4M | 110.3M | 120.0M | 41.0M | 59.0M | |
Other Current Assets | 8.7M | 5.1M | 5.4M | 2.1M | 13.9M | 14.6M | |
Total Liab | 220.5M | 196.5M | 174.5M | 191.5M | 227.4M | 132.8M | |
Property Plant And Equipment Gross | 54.5M | 45.4M | 40.6M | 44.1M | 78.4M | 82.4M | |
Total Current Assets | 185.5M | 230.0M | 162.6M | 98.5M | 235.4M | 158.0M | |
Accumulated Other Comprehensive Income | 267K | 389K | 181K | (29K) | (124K) | (117.8K) | |
Short Term Debt | 3.2M | 3.7M | 5.0M | 5.5M | 6.7M | 3.6M | |
Common Stock | 539.5M | 694.1M | 749.9M | 802.8M | 935.4M | 481.8M | |
Property Plant Equipment | 54.5M | 29.2M | 22.3M | 17.3M | 19.9M | 22.5M | |
Net Tangible Assets | 63.7M | 90.7M | 40.4M | (37.2M) | (33.5M) | (31.8M) | |
Other Stockholder Equity | 49.4M | 63.7M | 80.1M | 111.6M | 129.2M | 135.7M | |
Non Currrent Assets Other | 10.7M | 115K | 148K | 62K | 156K | 148.2K | |
Capital Surpluse | 57.3M | 71.6M | 88.0M | 119.4M | 137.4M | 144.2M | |
Capital Lease Obligations | 32.5M | 29.3M | 29.9M | 37.6M | 32.1M | 21.5M | |
Non Current Liabilities Other | 1.7M | 67.5M | 102.4M | 112.1M | 128.9M | 135.3M | |
Net Invested Capital | 63.7M | 82.8M | 32.5M | (45.1M) | 39.6M | 44.2M | |
Net Working Capital | 67.3M | 109.0M | 98.4M | 27.0M | 48.9M | 63.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.CRM | Salesforce | |
MSFT | Microsoft | |
S | SentinelOne |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stocks Directory Find actively traded stocks across global markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Wave Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.068 | Quarterly Revenue Growth 22.451 | Return On Assets (0.20) | Return On Equity (11.18) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.